Synonyms:hydroxyurea, 127-07-1, Hydroxycarbamide, N-Hydroxyurea, Hydrea, 1-HYDROXYUREA, Oxyurea, Carbamoyl oxime, Biosupressin, Hydroxycarbamine, Urea, hydroxy-, Onco-carbide, Carbamohydroxamic acid, Carbamohydroximic acid, Droxia, Hydura, Litalir, Carbamyl hydroxamate, Hydurea, N-Carbamoylhydroxylamine, Hidrix, Siklos, Hydroxicarbamidum, Hydroxylurea, Hydreia, Litaler, Idrossicarbamide [DCIT], Hidroxicarbamida, Hydroxyharnstoff, SQ 1089, Hydroxycarbamidum, Carbamohydroxyamic acid, N-Hydroxymocovina, Hydroxylamine, N-carbamoyl-, Hydroxyharnstoff [German], N-Hydroxymocovina [Czech], hydroxy urea, NCI-C04831, Hydroxylamine, N-(aminocarbonyl)-, SK 22591, Hydroxycarbamidum [INN-Latin], Hidroxicarbamida [INN-Spanish], urea, N-hydroxy-, HU, CCRIS 958, HYDROXY-UREA, NSC 32065, NSC32065, MFCD00007943, SQ-1089, AI3-51139, Ammonium ichthosulfonate, Hydroxyurea (Cytodrox), Hydroxycarbamide [INN], NSC-32065, 8029-68-3, CHEMBL467, X6Q56QN5QC, DTXSID6025438, CHEBI:44423, NCGC00015520-03, Hydroxycarbamid, Oncocarbide, Idrossicarbamide, NHY, Hydroxyurea (D4), DTXCID405438, N-HYDROXY UREA, Mylocel, carbamide oxide, Xromi, CAS-127-07-1, SMR000059149, Hydroxyurea (USP), Droxia (TM), Droxia (TN), Hydrea (TM), hydroxyaminomethanamide, HSDB 6887, SR-01000075919, DRG-0253, EINECS 204-821-7, HYDREA (TN), Hydroxyurea [USAN:USP], UNII-X6Q56QN5QC, BRN 1741548, Hydroxycarbamide (JAN/INN), hydroxyl urea, n-hydroxy-urea, S-phase/G-1 interface inhibitor, aminohydroxamic acid, carbamic acid oxime, Carbomohydroxamic acid, Spectrum_000909, WLN: ZVMQ, Hydrea (Bristol Meyers), HYDROXYUREA [MI], Spectrum2_000064, Spectrum3_000462, Spectrum4_000012, Spectrum5_000836, Lopac-H-8627, HYDROXYUREA [HSDB], HYDROXYUREA [IARC], HYDROXYUREA [USAN], MolMap_000029, H 8627, HYDROXYUREA [VANDF], NCIMech_000139, Hydroxyurea, 98%, powder, Lopac0_000596, BSPBio_002164, HYDROXYUREA [USP-RS], KBioGR_000383, KBioSS_001389, 4-03-00-00170 (Beilstein Handbook Reference), hydroxycarbamide (hydroxyurea), MLS001332381, MLS001332382, MLS002153389, DivK1c_000556, HYDROXYCARBAMIDE [JAN], N-(Aminocarbonyl)hydroxylamine, SPECTRUM1500344, SPBio_000247, GTPL6822, HYDROXYCARBAMIDE [MART.], tetratogen: inhibits ribonucleoside diphosphate reductase, HMS501L18, KBio1_000556, KBio2_001389, KBio2_003957, KBio2_006525, KBio3_001384, HYDROXYCARBAMIDE [WHO-DD], HYDROXYUREA [ORANGE BOOK], NINDS_000556, Bio1_000451, Bio1_000940, Bio1_001429, HMS1920F09, HMS2091L17, HMS2234I03, HMS3261H14, HMS3373G18, HMS3655K20, HMS3869C03, NCI C04831, Pharmakon1600-01500344, HYDROXYCARBAMIDE [EMA EPAR], HYDROXYUREA [USP MONOGRAPH], ACT02611, ALBB-028465, AMY40858, HY-B0313, STR02555, Tox21_110168, Tox21_300319, Tox21_500596, BBL009928, BDBM50017811, CCG-35236, NSC757072, s1896, STL145898, AKOS005716276, AKOS006222547, Tox21_110168_1, DB01005, HYDROXYCARBAMIDE [EP MONOGRAPH], LP00596, NSC-757072, SDCCGSBI-0050578.P006, IDI1_000556, NCGC00015520-01, NCGC00015520-02, NCGC00015520-04, NCGC00015520-05, NCGC00015520-06, NCGC00015520-07, NCGC00015520-08, NCGC00015520-09, NCGC00015520-10, NCGC00015520-11, NCGC00015520-20, NCGC00093974-01, NCGC00093974-02, NCGC00093974-03, NCGC00093974-04, NCGC00093974-05, NCGC00254007-01, NCGC00261281-01, AC-22674, NCI60_002773, SBI-0050578.P004, DB-041849, EU-0100596, FT-0627160, FT-0627175, FT-0670210, H0310, SW218071-2, EN300-82775, C07044, D00341, Hydroxyurea, Vetec(TM) reagent grade, >=98%, AB00052018-09, AB00052018-10, AB00052018_11, AB00052018_12, A805636, Q212272, J-504798, SR-01000075919-1, SR-01000075919-3, SR-01000075919-8, E0723DBA-5AF3-49D1-B5F6-59420AB87AC9, F8880-0905, Z1203577934, Hydroxycarbamide, European Pharmacopoeia (EP) Reference Standard, Hydroxyurea, United States Pharmacopeia (USP) Reference Standard
Pubchem:PUBCHEM:3657
Id:fab43c74-03bf-5ad7-b674-7ccaf5bb2115
Description:nan
